Hemab Therapeutics Holdings (COAG) insider trading in the last 6 months

Form 4 filings, newest first

Quality Score today 3

2 insiders bought $55.5M. No sales.

BuyRa Capital Management, L.P.$1.5M10% ownerat $24.98 on Jun 16, filed Jun 17

BuyRa Capital Management, L.P.10% owner$1.5Mat $24.98 on Jun 16, filed Jun 17

BuyRa Capital Management, L.P.$153K10% ownerat $24.89 on Jun 15, filed Jun 17

BuyRa Capital Management, L.P.10% owner$153Kat $24.89 on Jun 15, filed Jun 17

BuyRA Capital Management, L.P.$95K10% ownerat $24.97 on May 19, filed May 21

BuyRA Capital Management, L.P.10% owner$95Kat $24.97 on May 19, filed May 21

From SEC Form 4s, the newest filed Jun 17, 2026 · Insiders have 2 business days to file a trade

13 more filings on COAG in the last 6 months, for Pro members. See them free →

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 16 tradesSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Pro members see every filing on COAG with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Insider trades by person

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Questions about COAG's insider trades

As of Oct 26, 2026: Hemab Therapeutics Holdings (COAG) has 16 insider filings on record in the last 6 months, the newest filed Jun 17, 2026. Its Quality Score is 3 (Below Average). Scores as of 10:16 PM ET, 15 minutes behind.

Are COAG insiders buying or selling?

2 insiders bought $55.5M across 16 filings in the last 6 months. No open-⁠market sales on record. The newest filing: Ra Capital Management, L.P., 10% owner, bought $1.5M on Jun 16, 2026.

Who are COAG's biggest insider sellers?

No COAG insider sold shares on the open market in the last 6 months, as filed on Form 4.

When did a COAG insider last buy?

Ra Capital Management, L.P., 10% owner, bought COAG shares ($1.5M) on Jun 16, 2026, filed Jun 17, 2026, the newest insider buy on record.

Hemab Therapeutics Holdings's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.